
    
      Tegafur Gimeracil Oteracil Potassium Capsule is a novel oral derivative of the
      5-fluorouracil(5-FU) prodrug tegafur combined with two modulators. Recent clinical trial has
      reported the promising effect of Tegafur Gimeracil Oteracil Potassium Capsule in metastatic
      breast cancer. The innovative drug, S-1, has obtained the approval of treatment of advanced
      breast cancer in Japan, meanwhile, Generic drug is only approved for the indication of
      gastric cancer in China mainland by Chinese authority, SFDA, and no Chinese clinical study
      data of TS-1 in breast cancer so far.
    
  